Ajinomoto and RIBOMIC Join Forces to Enhance Aptamer Pharmacokinetics Using Innovative Technology The collaboration between Ajinomoto and RIBOMIC focuses on extending the pharmacokinetics of nucleic acid aptamers to improve drug efficacy, promising new advancements in pharmaceuticals.

Ajinomoto and RIBOMIC Join Forces to Enhance Aptamer Pharmacokinetics Using Innovative Technology #Japan #Tokyo #Ajinomoto #RIBOMIC #Aptamer

Innovative Research Enhances Pharmacokinetics of Nucleic Acid Aptamers in Collaboration with Ajinomoto and RIBOMIC Ajinomoto Co., Inc. and RIBOMIC Inc. have made significant strides in extending the pharmacokinetics of nucleic acid aptamers using cutting-edge technology, promising advancements in drug efficacy.

Innovative Research Enhances Pharmacokinetics of Nucleic Acid Aptamers in Collaboration with Ajinomoto and RIBOMIC #Japan #Tokyo #Ajinomoto #RIBOMIC #AJICAP